Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Primary Biliary Cholangitis Without Cirrhosis

NCT02943447 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02943447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02943447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Subjects With Primary Biliary Cholangitis Without Cirrhosis
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Terminated
Start date
December 1, 2016
Completion date
September 4, 2019
Enrollment
71 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis